The Lancet Oncology: 66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner

Click here to read the full press release.

AI Specialists Manchester Imaging Win UK Innovation Scholars Grant to Develop AI-enhanced Skin Cancer Detection Capability for Michelson Diagnostics’ VivoSight OCT Scanner

Click here to read the full press release.

Click here to read the full press release.

Click here to read the full press release.

Home

Click here to read full press release.

https://vivosight.com/?post_type=news&p=2764

https://vivosight.com/?post_type=news&p=2592

https://vivosight.com/?post_type=news&p=2551

https://vivosight.com/?post_type=news&p=2392